Literature DB >> 17914818

Anomeric reactivity-based one-pot synthesis of heparin-like oligosaccharides.

Tülay Polat1, Chi-Huey Wong.   

Abstract

A highly efficient one-pot methodology is described for the synthesis of heparin and heparan sulfate oligosaccharides utilizing thioglycosides with well-defined reactivity as building blocks. L-Idopyranosyl and D-glucopyranosyl thioglycosides 5 and 10 were used as donors due to low reactivity of uronic acids as the glycosyl donors in the one-pot synthesis. The formation of uronic acids by a selective oxidation at C-6 was performed after assembly of the oligosaccharides. The efficiency of this programmable strategy with the flexibility for sulfate incorporation was demonstrated in the representative synthesis of disaccharides 17, 18, tetrasaccharide 23, and pentasaccharide 26.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17914818      PMCID: PMC2525852          DOI: 10.1021/ja073098r

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  23 in total

1.  Synthesis of heparin partial structures and their binding activities to platelets.

Authors:  S Koshida; Y Suda; M Sobel; J Ormsby; S Kusumoto
Journal:  Bioorg Med Chem Lett       Date:  1999-11-01       Impact factor: 2.823

2.  Synthesis of nigero-oligosaccharides.

Authors:  K Takeo; S Kitamura; Y Murata
Journal:  Carbohydr Res       Date:  1992-02-07       Impact factor: 2.104

Review 3.  Proteoglycans: structures and interactions.

Authors:  L Kjellén; U Lindahl
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

4.  Synthesis of methyl glycoside derivatives of tri- and penta-saccharides related to the antithrombin III-binding sequence of heparin, employing cellobiose as a key starting-material.

Authors:  Y Ichikawa; R Monden; H Kuzuhara
Journal:  Carbohydr Res       Date:  1988-01-15       Impact factor: 2.104

5.  Programmable reactivity-based one-pot oligosaccharide synthesis.

Authors:  Jinq-Chyi Lee; William A Greenberg; Chi-Huey Wong
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

6.  Reactivity-based one-pot total synthesis of fucose GM1 oligosaccharide: a sialylated antigenic epitope of small-cell lung cancer.

Authors:  Tony Kwok-Kong Mong; Hing-Ken Lee; Sergio G Duron; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

7.  Synthesis of heparin oligosaccharides.

Authors:  Jinq-Chyi Lee; Xin-An Lu; Suvarn S Kulkarni; Yuh-Sheng Wen; Shang-Cheng Hung
Journal:  J Am Chem Soc       Date:  2004-01-21       Impact factor: 15.419

8.  Modular synthesis of heparin oligosaccharides.

Authors:  Hernán A Orgueira; Alessandra Bartolozzi; Peter Schell; Remy E J N Litjens; Emma R Palmacci; Peter H Seeberger
Journal:  Chemistry       Date:  2003-01-03       Impact factor: 5.236

9.  Novel efficient routes to heparin monosaccharides and disaccharides achieved via regio- and stereoselective glycosidation.

Authors:  Henry N Yu; Jun-ichi Furukawa; Tsuyoshi Ikeda; Chi-Huey Wong
Journal:  Org Lett       Date:  2004-03-04       Impact factor: 6.005

10.  N-(phenylthio)-epsilon-caprolactam: a new promoter for the activation of thioglycosides.

Authors:  Sergio G Durón; Tülay Polat; Chi-Huey Wong
Journal:  Org Lett       Date:  2004-03-04       Impact factor: 6.005

View more
  31 in total

Review 1.  Complexity in biomaterials for tissue engineering.

Authors:  Elsie S Place; Nicholas D Evans; Molly M Stevens
Journal:  Nat Mater       Date:  2009-06       Impact factor: 43.841

2.  Towards the assembly of heparin and heparan sulfate oligosaccharide libraries: efficient synthesis of uronic acid and disaccharide building blocks.

Authors:  Akihiro Saito; Masahiro Wakao; Hiroshi Deguchi; Aya Mawatari; Michael Sobel; Yasuo Suda
Journal:  Tetrahedron       Date:  2010-05-29       Impact factor: 2.457

3.  Chemical synthesis of syndecan-3 glycopeptides bearing two heparan sulfate glycan chains.

Authors:  Keisuke Yoshida; Bo Yang; Weizhun Yang; Zeren Zhang; Jicheng Zhang; Xuefei Huang
Journal:  Angew Chem Int Ed Engl       Date:  2014-06-30       Impact factor: 15.336

4.  Combinatorial one-pot chemoenzymatic synthesis of heparin.

Authors:  Ujjwal Bhaskar; Guoyun Li; Li Fu; Akihiro Onishi; Mathew Suflita; Jonathan S Dordick; Robert J Linhardt
Journal:  Carbohydr Polym       Date:  2014-11-07       Impact factor: 9.381

5.  Discovery of an intrinsic tenase complex inhibitor: Pure nonasaccharide from fucosylated glycosaminoglycan.

Authors:  Longyan Zhao; Mingyi Wu; Chuang Xiao; Lian Yang; Lutan Zhou; Na Gao; Zi Li; Jun Chen; Jianchao Chen; Jikai Liu; Hongbo Qin; Jinhua Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-22       Impact factor: 11.205

6.  Obstacles and solutions for chemical synthesis of syndecan-3 (53-62) glycopeptides with two heparan sulfate chains.

Authors:  Weizhun Yang; Keisuke Yoshida; Bo Yang; Xuefei Huang
Journal:  Carbohydr Res       Date:  2016-10-20       Impact factor: 2.104

7.  Programmable One-Pot Synthesis of Heparin Pentasaccharide Fondaparinux.

Authors:  Supriya Dey; Hong-Jay Lo; Chi-Huey Wong
Journal:  Org Lett       Date:  2020-06-04       Impact factor: 6.005

8.  Preactivation-based, one-pot combinatorial synthesis of heparin-like hexasaccharides for the analysis of heparin-protein interactions.

Authors:  Zhen Wang; Yongmei Xu; Bo Yang; Gopinath Tiruchinapally; Bin Sun; Renpeng Liu; Steven Dulaney; Jian Liu; Xuefei Huang
Journal:  Chemistry       Date:  2010-07-26       Impact factor: 5.236

9.  Modular synthesis of heparan sulfate oligosaccharides for structure-activity relationship studies.

Authors:  Sailaja Arungundram; Kanar Al-Mafraji; Jinkeng Asong; Franklin E Leach; I Jonathan Amster; Andre Venot; Jeremy E Turnbull; Geert-Jan Boons
Journal:  J Am Chem Soc       Date:  2009-12-02       Impact factor: 15.419

Review 10.  Recent progress in chemical and chemoenzymatic synthesis of carbohydrates.

Authors:  Saddam Muthana; Hongzhi Cao; Xi Chen
Journal:  Curr Opin Chem Biol       Date:  2009-10-14       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.